Full Data
?
UNLOCK DATA
Subscribe & Access the Best Data and Intelligence on the Chinese Stock Markets
Join Now!
Need this critical market data?
Access thousands of market events, data points, and news articles!
Already have an account?
Login
Home » News » The dual main business of Songfa Co., Ltd. suffered setbacks: in 2021, the gross profit margin will be cut by more than 300 million yuan and rely on Hengli Group for blood transfusion.